异基因造血干细胞移植后T细胞免疫重建与移植物抗宿主病
摘要
异基因造血干细胞移植(Allo—HSCT)后的免疫重建与移植物抗肿瘤/白血病(GVT/GVL)效应,及移植物抗宿主病(GVHD)、移植后感染等均有密切关系。T细胞是细胞免疫、体液免疫的调节与效应细胞,在移植后的免疫重建中占有重要位置。由于供者T细胞活化是GVHD发生的关键环节,T细胞的恢复与GVHD密切相关。因而了解T细胞的免疫重建具有重要意义。本文着重描述Allo—HSCT后T细胞重建及其与GVHD的关系。
出处
《临床血液学杂志》
CAS
2006年第3期187-190,共4页
Journal of Clinical Hematology
参考文献21
-
1Fujimaki K,Maruta A,Yoshida M,et al.Immune reconstitution assessed during five years after allogeneic bone marrow transplantation.Bone Marrow Transplant,2001,27:1275-1281.
-
2孙自敏,王祖贻,刘会兰,刘欣,朱薇波,韩永胜,杨会志,潘理明,吴树农,吴竟生.异基因造血干细胞移植治疗恶性血液病[J].临床血液学杂志,2004,17(5):257-260. 被引量:5
-
3Dumont-Girard F,Roux E,van Lier R A,et al.Reconstitution of the T-cell compartment after bone marrow transplantation:restoration of the repertoire by thymic emigrants.Blood,1998,92:4464-4471.
-
4Heitger A,Neu N,Kern H,et al.Essential role of the thymus to reconstitute naive (CD45RA +) T-helper cells after human allogeneic bone marrow transplantation.Blood,1997,90:850-857.
-
5Storek J,Gooley T,Witherspoon R P,et al.Infectious morbidity in long-term survivors of allogeneic transplantation is associated with low CD4 T cell counts.Am J Hematol,1997,54:131-138.
-
6Hentschke P,Omazic B,Mattsson J,et al.T-cell receptor Vbeta repertoire after myeloablative and reduced intensity conditioning allogeneic haematopoietic stem cell transplantation.Scand J Immunol,2005,61:285-294.
-
7Andreas K K,Dhavalkumar D P,Maria E G,et al.T-Cell recovery in adults and children following umbilical cord blood transplantation.Biol Blood Marrow Transplant,2001,7:454-466.
-
8Avigan D,Wu Z,Kufe D,et al.Immune reconstitution following high-dose chemotherapy with stem cell rescue in patients with advanced breast cancer.Bone Marrow Transplant,2000,26:169-176.
-
9Ottinger H D,Beelen D W,Scheulen B,et al.Improved immune reconstitution after Allo-transplantation of peripheral blood stem cells instead of bone marrow.Blood,1996,88:2775-2779.
-
10Small T N,Papadopoulos E B,Boulad F,et al.Comparison of immune reconstitution after unrelated and relate T-cell-depleted bone marrow transplantation:effect of patient age and donor leukocyte infusions.Blood,1999,93:467-480.
二级参考文献23
-
1Abu-Ghosh A, Goldman S, Slone V, et al. Immuno logical reconstitution and correlation of circulating serum inflammatory mediators/cytokines with the incidence of acute graft-versus-host disease during the first 100 days following unrelated umbilical cord
-
2Fujimaki K, Maruta A, Yoshida M, et al Immune reconstitution assessed during five years after allogeneic bone marrow transplantation. Bone marrow transplantation, 2001, 27: 1275-1281.
-
3Laughlin M J,Barker J,Bambach B,et al. Hematopoitic engraftment and survival in adult recipients of umbilical cord blood from unrelated donors. N Engl J Med, 2001,344:1815-1822.
-
4Ottinger H D, Beelen D W,Scheulen B,et al. Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow. Blood.1996,88: 2775- 2779.
-
5Locatelli F, Rocha V, Chastang C,et al. Factors associated with outcome after cord blood transplantation in children with acute leukemia. Blood, 1999, 93:3662 -3671.
-
6Lamb LS, Gee AP, Henslee-Downey PJ, et al. Phenotypic and functional reconstitution of peripheral blood lymphocytes following T cell-depleted bone marrow transplantation from partially mismatched related donors. Bone Marrow Transplant, 1998; 21:461 - 471
-
7Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation,1974; 18:295- 304
-
8Foley R, Couban S, Walker I, et al. Monitoring soluble interleukin-2 receptor levels in related and unrelated donor allogenic bone marrow transplantation. Bone Marrow Transplant, 1998; 21:769 - 773
-
9Soiffer RJ, Gonin R, Murray C, et al. Prediction of graftversus-host disease by phenotypic analysis of early immunc reconstitution after CD6-depleted allogeneic bone marrow transplantation. Blood, 1993; 82: 2216 - 2223
-
10Garderet L, Snell V, Przepiorka D, et al. Effective depletion of alloreactive lymphocytes from peripheral blood mononuclear cell preparations. Transpantation, 1999; 67:124 -130
共引文献9
-
1鲍自谦,周丹,邹红岩,邓志辉.无关供者骨髓移植中HLA-C_W基因与急性GVHD相关性的初探[J].江西医学检验,2006,24(2):105-106.
-
2蔡正文,赖永榕,莫武宁,马劼,彭志刚,刘汉锋.异基因干细胞移植后T细胞重建及与慢性移植物抗宿主病关系的研究[J].广西医科大学学报,2006,23(2):199-202.
-
3贾新颜,王健民,李扬秋,陈少华,章卫平,陈莉.异基因造血干细胞移植患者外周血TCR Vβ亚家族克隆性增殖动态变化及其与GVHD的关系[J].中国实验血液学杂志,2007,15(4):795-800. 被引量:1
-
4洪鸣,李建勇,钱思轩,吴汉新,陆化,张闰,张晓艳,徐卫.异基因造血干细胞移植后免疫重建临床研究[J].中国实验血液学杂志,2008,16(5):1130-1134. 被引量:11
-
5张善堂,孙自敏.白消安在造血干细胞移植中的应用及其治疗药物监测研究进展[J].中国医院药学杂志,2009,29(3):228-232. 被引量:1
-
6张善堂,方焱,孙自敏,刘会兰,耿良权,唐丽琴,孙言才,吴云,谯川南,屈建.静脉输注白消安在异基因造血干细胞移植预处理患者体内的药动学研究[J].中国药学杂志,2010,45(12):935-939. 被引量:11
-
7卫蓓文,唐暐,彭奕冰,胡炯.全相合异基因造血干细胞移植后免疫重建的研究[J].检验医学,2014,29(9):925-929. 被引量:6
-
8沈耀耀,刘跃均,吴德沛,陈佳,徐杨,薛胜利,周海侠,李晓莉,朱明清.异基因造血干细胞移植后免疫重建的临床研究及急性移植物抗宿主病的危险因素分析[J].白血病.淋巴瘤,2015,24(6):346-351. 被引量:8
-
9王健民.异基因造血干细胞移植的几个重要问题[J].第二军医大学学报,2002,23(9):929-932.
-
1周学慧,冯四洲.异基因造血干细胞移植患者侵袭性真菌感染的防治对策[J].中国实用内科杂志,2006,26(7):1033-1035. 被引量:3
-
2谢蜀生.免疫重建[J].科技导报,1994,12(2):14-16.
-
3邢俊平,陈勇,薛武军,田普训.成人型多囊肾与肾移植(附8例报告)[J].现代泌尿外科杂志,1997,2(1):16-18.
-
4张银甫,张邦燮.肾移植后感染和排斥反应监测指标的探讨[J].中华器官移植杂志,1993,14(2):53-58. 被引量:3
-
5王斌,宫巧红,吕国栋,王军,谢胜利.胸部创伤165例的影像学分析[J].中国乡村医药,2005,12(10):56-57.
-
6顾延刚,逄林.老年人骨折手术后并发肺炎16例临床分析[J].山东医药,2006,46(8):83-83. 被引量:1
-
7邸生文.中西医结合治疗肾病综合征[J].中国实用医药,2009,4(9):154-154. 被引量:2
-
8任小朋,张玉勤.心脏直视手术的围手术期处理体会[J].陕西中医学院学报,2005,28(2):13-14.
-
9孙国顺,吴云县.改良kessler法一期修复屈肌腱损伤35例报告[J].中国医师杂志,2002,4(7):763-763. 被引量:2
-
10张秋蓉,唐晓文,冯宇锋,朱子玲,常伟荣,孙爱宁,吴德沛.CD3^+T细胞嵌合率与急性移植物抗宿主病关系的研究[J].中华血液学杂志,2008,29(9):641-642.